HEALTHSOURCE SAGINAW INC. — History
CCN 230275 | 3-year financial timeline | COVID resilience: 20/100
🛡️ Public data only — no PHI permitted on this instance.
$41M
Latest Revenue (FY2022)
-10.1%
Revenue CAGR (3yr)
-28.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $51M | $44M | $41M | -5.7% | -10.1% |
| Operating Expenses | $52M | $56M | $53M | -6.2% | +1.4% |
| Operating Margin | -1.3% | -29.5% | -28.9% | +2.0% | +0.0% |
| Net Income | $-1M | $-13M | $-12M | +7.6% | +0.0% |
| Licensed Beds | 7 | 7 | 7 | +0.0% | +0.0% |
| Total Patient Days | 1,262 | 1,049 | 1,119 | +6.7% | -5.8% |
| Medicare Day % | 10% | 11% | 7% | -35.1% | -14.9% |
| Medicaid Day % | 62% | 65% | 63% | -3.1% | +0.4% |
COVID Impact & Recovery
Resilience Score: 20/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -19.2% ($51M → $41M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-10.1%
This Hospital
+7.6%
State Avg
Latest Margin
-28.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $36M | -42.7% |
| FY2024 (proj) | $31M | -56.5% |
| FY2025 (proj) | $26M | -70.3% |